Net profit of Concord Biotech rose 18.17% to Rs 95.74 crore in the quarter ended September 2024 as against Rs 81.02 crore during the previous quarter ended September 2023. Sales rose 18.23% to Rs 310.18 crore in the quarter ended September 2024 as against Rs 262.35 crore during the previous quarter ended September 2023.
Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
Sales | 310.18 | 262.35 | 18 |
OPM % | 43.11 | 44.11 | - |
PBDT | 143.65 | 123.00 | 17 |
PBT | 130.34 | 109.70 | 19 |
NP | 95.74 | 81.02 | 18 |